These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11112777)

  • 1. Rational design of a peptide agonist that interacts selectively with the orphan receptor, bombesin receptor subtype 3.
    Mantey SA; Coy DH; Pradhan TK; Igarashi H; Rizo IM; Shen L; Hou W; Hocart SJ; Jensen RT
    J Biol Chem; 2001 Mar; 276(12):9219-29. PubMed ID: 11112777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.
    Ryan RR; Weber HC; Hou W; Sainz E; Mantey SA; Battey JF; Coy DH; Jensen RT
    J Biol Chem; 1998 May; 273(22):13613-24. PubMed ID: 9593699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of bombesin analogs with conformationally restricted amino acid substitutions with enhanced selectivity for the orphan receptor human bombesin receptor subtype 3.
    Mantey SA; Coy DH; Entsuah LK; Jensen RT
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1161-70. PubMed ID: 15102928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of putative selective hBRS-3 receptor agonists for human bombesin receptors (BnR): affinities, potencies and selectivity in multiple native and BnR transfected cells.
    Sancho V; Moody TW; Mantey SA; Di Florio A; Uehara H; Coy DH; Jensen RT
    Peptides; 2010 Aug; 31(8):1569-78. PubMed ID: 20438784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis for agonist selectivity and activation of the orphan bombesin receptor subtype 3 receptor.
    Gonzalez N; Hocart SJ; Portal-Nuñez S; Mantey SA; Nakagawa T; Zudaire E; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2008 Feb; 324(2):463-74. PubMed ID: 18006692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors.
    Moreno P; Mantey SA; Nuche-Berenguer B; Reitman ML; González N; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2013 Oct; 347(1):100-16. PubMed ID: 23892571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology and selectivity of various natural and synthetic bombesin related peptide agonists for human and rat bombesin receptors differs.
    Uehara H; González N; Sancho V; Mantey SA; Nuche-Berenguer B; Pradhan T; Coy DH; Jensen RT
    Peptides; 2011 Aug; 32(8):1685-99. PubMed ID: 21729729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors.
    Mantey SA; Weber HC; Sainz E; Akeson M; Ryan RR; Pradhan TK; Searles RP; Spindel ER; Battey JF; Coy DH; Jensen RT
    J Biol Chem; 1997 Oct; 272(41):26062-71. PubMed ID: 9325344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of bombesin receptor subtype-specific ligands: effect of N-methyl scanning, truncation, substitution, and evaluation of putative reported selective ligands.
    Mantey SA; Gonzalez N; Schumann M; Pradhan TK; Shen L; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2006 Nov; 319(2):980-9. PubMed ID: 16943256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of high affinity bombesin receptor subtype 3 agonists.
    Wu JM; Nitecki DE; Biancalana S; Feldman RI
    Mol Pharmacol; 1996 Nov; 50(5):1355-63. PubMed ID: 8913368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.
    Wang LH; Battey JF; Wada E; Lin JT; Mantey S; Coy DH; Jensen RT
    Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):641-8. PubMed ID: 1326946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Characterization of a Novel, High-Affinity, Specific, Radiolabeled Ligand for BRS-3 Receptors.
    Ramos-Alvarez I; Lee L; Mantey SA; Jensen RT
    J Pharmacol Exp Ther; 2019 Jun; 369(3):454-465. PubMed ID: 30971479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3.
    Weber D; Berger C; Heinrich T; Eickelmann P; Antel J; Kessler H
    J Pept Sci; 2002 Aug; 8(8):461-75. PubMed ID: 12212809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes.
    Pradhan TK; Katsuno T; Taylor JE; Kim SH; Ryan RR; Mantey SA; Donohue PJ; Weber HC; Sainz E; Battey JF; Coy DH; Jensen RT
    Eur J Pharmacol; 1998 Feb; 343(2-3):275-87. PubMed ID: 9570477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
    Lin JT; Coy DH; Mantey SA; Jensen RT
    J Pharmacol Exp Ther; 1995 Oct; 275(1):285-95. PubMed ID: 7562561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning and characterization of avian bombesin-like peptide receptors: new tools for investigating molecular basis for ligand selectivity.
    Iwabuchi M; Ui-Tei K; Yamada K; Matsuda Y; Sakai Y; Tanaka K; Ohki-Hamazaki H
    Br J Pharmacol; 2003 Jun; 139(3):555-66. PubMed ID: 12788815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A selective human bombesin receptor subtype-3 peptide agonist mediates CREB phosphorylation and transactivation.
    Qin X; Qu X; Coy D; Weber HC
    J Mol Neurosci; 2012 Jan; 46(1):88-99. PubMed ID: 22127929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the peptide structural requirements for high affinity interaction with bombesin receptors.
    Lin JT; Coy DH; Mantey SA; Jensen RT
    Eur J Pharmacol; 1995 Dec; 294(1):55-69. PubMed ID: 8788416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of putative GRP- and NMB-receptor antagonist's interaction with human receptors.
    González N; Mantey SA; Pradhan TK; Sancho V; Moody TW; Coy DH; Jensen RT
    Peptides; 2009 Aug; 30(8):1473-86. PubMed ID: 19463875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of four amino acids in the gastrin-releasing peptide receptor that are required for high affinity agonist binding.
    Akeson M; Sainz E; Mantey SA; Jensen RT; Battey JF
    J Biol Chem; 1997 Jul; 272(28):17405-9. PubMed ID: 9211882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.